MeSH tree: D12.776.543.750.695.021.500.500
Stopping weight loss drugs is followed by weight regain and reversal of beneficial effects on heart and metabolic health markers such as high cholesterol and high blood pressure, finds a study published in The BMJ.
Jan 7, 2026
0
17
Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.
Jan 7, 2026
0
13
For millions of people, weight-loss injections such as Wegovy and Mounjaro have felt like a breakthrough that finally makes eating less feel easier. In a few short years, these so-called GLP-1 drugs have reshaped how obesity ...
Jan 6, 2026
0
9
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic CV disease, according ...
Dec 30, 2025
0
16
Private health insurance premiums will be going up in 2026—in some cases, by a lot.
Dec 16, 2025
0
24
Even when Americans have health insurance, they can have a hard time affording the drugs they've been prescribed.
Dec 16, 2025
0
6
A preliminary study of people with diabetes suggests that use of glucose-lowering GLP-1 drugs may be linked to a lower risk of developing epilepsy. The study was published in Neurology.
Dec 10, 2025
0
14
A systematic review and meta-analysis evaluated the risk for obesity-related cancer associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes (T2D) or overweight or obesity.
Dec 8, 2025
0
14
In a new paper published in Clinical Nutrition, "Sarcopenic Diabetes Is an Under-Recognized and Unmet Clinical Priority," nutrition and diabetes experts are calling attention to a little-known but serious complication of ...
Dec 1, 2025
0
18
Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease associated with substantial morbidity, mortality, and economic burden.
Dec 1, 2025
0
25
